Overturning expectations at the Dover Grand Hotel, Francesca Corelli, a medical doctor in Asia and Europe with 29 years of experience, delivers an informative talk on the current conditions of epidemics that is both amusing and surprising. No one at the event, no less than the French president Emmanuel Macron, gets sick to their stomachs when she announces that epidemics are now resistant to regular curative drugs. When the head of state enters her room, the wise doctor makes her physical-illness doc up a little but not much.

First stop on this circuit, fifty miles north of Paris, is the Saint-Joré Institute - a research institute that fights epidemics with the objective of identifying and devising preventive measures. And second stop is the University of Strasbourg, which has five labs for laboratory diagnostics.

And in total, there are eight hospitals to offer diagnostic tests and treatment if there is a lack of medical staff. New and improved, several hospitals went through what the team deemed a successful reconstruction. In order to make treatments 100% effective, the St. Mary’s Hospital is equipped with an incubator that can keep up to nine patients simultaneously.

L’artista l’ha fatto ancora

During the outbreak in Brazil, doctors discovered that Coronavirus made a great patient in New York. Compared to the outbreak of MERS in Miami, this virus was extremely efficient, in 100 days killing 85% of its victims, making New York 100 times more successful.

The outbreak that followed was the worst ever. In 2016, the case with Avian influenza broke out in Europe. This spread from Croatia to Belgium with no restrictions. But when a patient from the Balkans was found in Lyon in France, he could not be trusted, and the entire operation was halted. He was registered as Coronavirus, which was too similar to MERS and caused the worst human-E. coli epidemic ever in Italy.

This outbreak also provided an opportunity to develop diagnostic tests for the virus that have already been successful in a few countries, including Spain, Italy, the United States, and, most recently, Germany. The State of California has even planned to develop a vaccine in order to protect against the epidemic.

How long will the epidemic?

New information will continue to be gained from, first, epidemiological and diagnostic studies; second, vaccines; third, the creation of drugs; and fourth, epidemiological profiles of the victims; and finally, from the populations of countries where the epidemic is arriving.